Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06727890
PHASE4

Compound Danshen Dripping Pill for Diabetic Microvascular Angina

Sponsor: Qilu Hospital of Shandong University

View on ClinicalTrials.gov

Summary

To investigate the efficacy and safety of Compound Danshen Dripping Pill in patients with diabetic microvascular angina pectoris. Long-term follow-up of 1 year will be performed to evaluate the effect of Compound Danshen Dripping Pill on coronary flow reserve and adverse cardiovascular events in patients with coronary microvascular disease.

Official title: The Efficacy and Safety of Compound Danshen Dripping Pill in Patients With Diabetic Microvascular Angina

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

162

Start Date

2025-01-01

Completion Date

2027-06-30

Last Updated

2024-12-11

Healthy Volunteers

No

Interventions

DRUG

Danshen Dripping Pill

Danshen Dripping Pill, 10 pills once, three times a day

DRUG

Placebo

Placebo, 10 pills once, three times a day

Locations (3)

Qilu Hospital of Shandong University

Jinan, Shandong, China

Central Hospital Affiliated to Shandong First Medical University

Jinan, Shandong, China

The First Affiliated Hospital of Shandong First Medical University/Shandong Province Qianfoshan Hospital

Jinan, Shandong, China